WILCOX, MARK HARVEY,BAINES, SIMON,LEHOUX, DARIO,PARR, THOMAS R.
申请号：
CA2699550
公开号：
CA2699550C
申请日:
2008.09.11
申请国别(地区):
CA
年份:
2020
代理人:
摘要：
Glycopeptide antibiotics, such as oritavancin, demonstrate significantactivity against both a vegetative form of C.difficile and C. difficile spores. Methods for the treatment, prophylaxis andprevention of C. difficile infection and disease in animals,including humans, are described.
